HealthTech

Oura Ring product representing Oura valuation, IPO pricing, Nasdaq listing plans, investor demand and the smart ring maker’s decision to postpone its offering

Oura Shelves $2.2 Billion IPO, Choosing Price Over Timing

A fourfold oversubscribed book was not enough. The smart ring maker walked away hours before pricing, betting that patience will secure better terms than a skittish fall market.

Tech IconsSep 29, 2026HealthTechIPOWearables

Hims & Hers Health Q2 2026 earnings and financial results, showing the company amid record revenue growth, international expansion following the Eucalyptus acquisition, weight loss and GLP-1 business changes, and mounting legal and regulatory risk from the FTC privacy lawsuit.

Hims & Hers Posts Record Revenue Amid Mounting Legal Risk

A 38 percent revenue surge and rapid global expansion collided with a surprise net loss, a new legal reserve, and an unresolved FTC privacy lawsuit in the second quarter of 2026.

Tech IconsAug 11, 2026Digital HealthEarnings ReportHealthTech

Scientist holding a laboratory test tube during pharmaceutical research at Novo Nordisk, illustrating Ziltivekimab, ZEUS trial, IL-6 inhibitor research, cardiovascular inflammation therapy, heart disease treatment and clinical drug development.

Novo Nordisk's Ziltivekimab Fails Pivotal Heart Trial

Ziltivekimab reduced cardiovascular inflammation exactly as designed, yet failed to cut heart attacks, strokes, or cardiovascular death, sending Novo Nordisk shares down sharply.

Tech IconsJul 31, 2026BiotechHealthcarePharmaceuticals

Eli Lilly Q1 2026 results reflecting tirzepatide sales surge, Mounjaro and Zepbound growth, and expanding GLP-1 drug market demand

Eli Lilly Posts 56% Revenue Surge as Incretin Empire Expands

Tirzepatide demand, oral GLP-1 approval, and raised full-year guidance confirm Eli Lilly's grip on the world's most consequential pharmaceutical franchise.

Tech IconsApr 30, 2026BiotechDrug DiscoveryPharmaceuticals

Novartis Q1 2026 earnings show Novartis Kisqali growth, Novartis Pluvicto sales, Novartis Entresto decline and Novartis pharma growth across Novartis drug portfolio, Novartis financial results, Novartis revenue and growth, Novartis oncology drugs, Novartis patent expiry impact, Novartis growth brands, Novartis drug sales growth and Novartis pharma strategy

Novartis Q1 2026 Earnings Show Growth Beyond Patent Cliff

Read more

OpenAI pharmaceutical partnership Novo Nordisk AI drug discovery healthcare AI digital transformation Novo Nordisk OpenAI alliance AI strategy

Novo Nordisk and OpenAI Join Forces to Reshape Drug Discovery

Read more

Woman wearing a Whoop fitness tracker during an ice bath recovery session as Whoop launches its women’s health biomarker panel, integrating wearable data with women’s health biomarkers.

Whoop Launches Women’s Biomarker Panel as Femtech Surges

Read more

Eli Lilly headquarters as weight-loss drugs Mounjaro and Zepbound drive record quarterly revenue

Lilly Delivers Record Q4 as Weight-Loss Drugs Rewrite Economics

Read more

The Strava app displayed on a smartphone, highlighting the platform’s activity tracking and social features ahead of its planned IPO.

Strava Files for IPO at $2.2B Valuation, $500M Revenue

Read more

Becky Quick, CNBC journalist and host, photographed in a studio setting ahead of the CNBC Cures Summit on rare disease research, Becky Quick brings rare disease innovation into focus through CNBC Cures, uniting science, patients and policy to accelerate genetic research.

Becky Quick and CNBC Cures: Advancing Rare Disease Innovation

Read more

President Donald Trump meets pharmaceutical executives at the White House as Medicare pricing reforms set the stage for oral Wegovy’s FDA approval.

Trump Administration Medicare Deal Powers Novo's Oral Rollout

Read more

Novartis global headquarters as the company announces a $1.7 billion AI drug discovery partnership with Relation Therapeutics.

Novartis Commits $1.7 Billion to AI-Driven Drug Discovery

Read more

AI Cyberattacks Surge as Deepfakes and ML Breach Defenses

Workday Reports Data Breach Through Third-Party CRM System

Security Flaw in Perplexity's Comet AI Browser Exposes User Data

DDoS Attacks Overwhelm Global Digital Networks via IoT Botnets

AI Tools Turn Hackers Into Sophisticated Cybercrime Threat

Oura Ring product representing Oura valuation, IPO pricing, Nasdaq listing plans, investor demand and the smart ring maker’s decision to postpone its offering

Oura Shelves $2.2 Billion IPO, Choosing Price Over Timing

Read more

Claude displayed on a mobile phone as Anthropic's $35 billion Nvidia cloud deal with Lambda expands Claude AI infrastructure, cloud computing and AI compute capacity

Inside Anthropic's $35 Billion Bet on NVIDIA's Cloud

Read more

Nvidia's $12.9 Billion Bid for AI's Open-Source Backbone

Read more